Active ingredient
Galcanezumab
3 finished FDA listings contain Galcanezumab as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- GALCANEZUMAB
- Dosage forms
- Injection, Solution
- Routes
- Subcutaneous
- Manufacturers / labelers
- 1
- Strengths listed
- 100 mg/ml · 120 mg/ml
- Brand names in FDA listings
- Emgality
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 2058846
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| BLA 761063 | ELI LILLY AND CO | 2018-09-27 | 3 |
Official labeling on DailyMed
- EMGALITY (GALCANEZUMAB-GNLM) INJECTION, SOLUTION [ELI LILLY AND COMPANY] · version 17 · 2026-06-18
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.